查看文章

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

作者

Fenici P Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen M, Thuresson M, Arya N, Bodegård J, Hammar N, CVD-REAL Investigators and Study Group

发表日期

2017/5/17

期刊

Circulation

卷号

136

期号

页码范围

249-259

出版商

Circulation

引用总数

被引用次数：873

2017201820192020202120222023202437 187 172 131 129 94 62 40

学术搜索中的文章

Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors)*

M Kosiborod, MA Cavender, AZ Fu, JP Wilding… - Circulation, 2017

被引用次数：759 相关文章所有 20 个版本

Lower risk of heart failure and death in patients initiated on SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study

M Kosiborod, MA Cavender, AZ Fu, JP Wilding… - Circulation, 2017

被引用次数：122 相关文章